Titel

Merkliste
1 Ergebnisse

Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adeno..:

Liu YT ; Hao XZ ; Liu DR...
https://www.dovepress.com/icotinib-as-adjuvant-treatment-for-stage-ii-iiia-lung-adenocarcinoma-p-peer-reviewed-article-CMAR. , 2020

Link: https://doaj.org/article/fc148cade0ba40449eb16b7d24d98..

RT Journal
T1 <Title>Icotinib as Adjuvant Treatment for Stage II-IIIA Lung Adenocarcinoma Patients with EGFR Mutation (ICWIP Study): Study Protocol for a Randomised Controlled Trial</Title>

UL https://suche.suub.uni-bremen.de/peid=base-ftdoajarticles:oai:doaj.org_article:fc148cade0ba40449eb16b7d24d98cec&Exemplar=1&LAN=DE
				
A1 Liu YT
A1 Hao XZ
A1 Liu DR
A1 Cheng G
A1 Zhang SC
A1 Xiao WH
A1 Hu Y
A1 Liu JF
A1 He M
A1 Ding CM
A1 Zhang L
A1 Wang J
A1 Li H
A1 Dong GL
A1 Zhi XY
A1 Li J
A1 Shi YK
PB Dove Medical Press
YR 2020
K1 efgr mutation
K1 non-small-cell lung cancer (nsclc)
K1 lung adenocarcinoma
K1 icotinib
K1 adjuvant chemotherapy
K1 Neoplasms. Tumors. Oncology. Including cancer and carcinogens
K1 RC254-282
JF https://www.dovepress.com/icotinib-as-adjuvant-treatment-for-stage-ii-iiia-lung-adenocarcinoma-p-peer-reviewed-article-CMAR
LK http://dx.doi.org/https://doaj.org/article/fc148cade0ba40449eb16b7d24d98cec
DO https://doaj.org/article/fc148cade0ba40449eb16b7d24d98cec
SF ELIB - SuUB Bremen

Export

RefWorks (nur Desktop-Version!)
Flow (Zuerst in Flow einloggen, dann importieren)